What Tom Green's Story Can Teach Us About Testicular Cancer

What he has said about it

Tom Green was 28 in 2000, with a show at the top of MTV's ratings, when he was told he had testicular cancer.

Speaking to CBC's Q in 2024, he described it as terrifying and traumatic. He also described what happened next in plain terms: his right testicle was removed, and so were lymph nodes. Production on his show stopped while he recovered.

Then he made a television program about it. The Tom Green Cancer Special ran an hour on MTV and used his own comedy to document the run-up to his surgeries, including footage from the procedures. He also set up a fund to raise money for cancer research.

Those are the facts he has put on the record himself. This page does not go past them.

Two operations, not one

The detail worth pausing on is the second surgery, because most write-ups skip it.

Removing the affected testicle is called an orchiectomy. It is both the treatment and the way the diagnosis is confirmed, since the tissue goes to a pathologist.

Removing lymph nodes is a separate and much bigger operation. Testicular cancer spreads in a predictable path, first to lymph nodes deep at the back of the abdomen near the major blood vessels. Taking those out is called a retroperitoneal lymph node dissection.

That predictability is unusual among cancers, and it is one reason this disease is so treatable. The route is known, so it can be watched or cleared.

Why the outlook is what it is

NCI's clinical summary opens with a sentence it does not write about many cancers: testicular cancer is highly treatable and usually curable, and it develops most often in young and middle-aged men.

Most cases are germ cell tumors, arising from the cells that make sperm. For treatment they split into two groups. Seminomas, where the cure rate across all stages exceeds 90%. And nonseminomas, everything else, including any tumor with a mix of both. For low-stage disease of either kind, NCI puts the cure rate close to 100%.

The American Cancer Society projects about 9,810 new testicular cancer diagnoses in the United States in 2026 and about 630 deaths, and SEER carries those projections. Median age at diagnosis is 33, which put Green in the ordinary range rather than an unlucky one.

Five-year relative survival across all stages is 94.6% for people diagnosed from 2016 through 2022. That is a group statistic describing a large population, not a promise to any individual, and it does not account for stage or subtype.

The blood tests that do much of the work

Three markers in the blood shape staging and follow-up here in a way that has no real equivalent in most cancers.

Alpha-fetoprotein, or AFP, is raised in 40% to 60% of men with nonseminomas. Seminomas do not produce it at all, so a raised AFP means the tumor is a nonseminoma even if the pathology report says otherwise.

Beta-hCG is raised in about 14% of men with stage I pure seminoma before surgery, in roughly half of those with metastatic seminoma, and in 40% to 60% of nonseminomas.

Lactate dehydrogenase, or LDH, can rise in either, and NCI is candid that its meaning is unclear because so many non-cancer conditions raise it too. In one study of 499 men, 7.7% had a raised LDH unrelated to cancer against 1.4% whose rise was cancer-related.

NCI notes these should be measured before the testicle is removed, and that a rising AFP or beta-hCG is often the earliest sign that disease has returned, sometimes before anything shows on a scan. It also warns about false positives, including cross-reaction with luteinizing hormone.

When to get checked

There is no screening test for testicular cancer, so this comes down to noticing a change.

NCI's list of things to have looked at:

• A painless lump or swelling in either testicle
• A change in how a testicle feels
• A dull ache low in the abdomen or in the groin
• Fluid building up in the scrotum, suddenly
• Pain or discomfort in a testicle or the scrotum

The first item is the one that matters most, and it is the one most easily talked away. A lump that does not hurt feels like a reason to wait. It is not.

Green told CBC there was a week when he had no intention of telling anyone. That reflex is common, and it is the thing his special was built to interrupt. Our page on the testicular self-exam describes what to feel for.

NCI's risk list is short: an undescended testicle, a family history in a father or brother, and a personal history of testicular cancer.

What this does not mean

Green's case was his own. Nothing here says what stage he had, because he has not said, and the size of an operation does not reveal a stage to anyone reading about it.

High cure rates across a population are also not the same as an easy experience. Surgery, and for many people chemotherapy after it, carry real effects, and follow-up runs for years. Our pages on testicular cancer and on life after treatment cover what that involves.

And a 25-year-old television special is a prompt to get something checked, not a treatment guide. What has not aged is the instruction underneath it: say the awkward thing to a doctor.

Sources

• CBC Arts: Why Tom Green says he's 'glad' he got testicular cancer at 28
• NCI PDQ: Testicular Cancer Treatment (Health Professional Version)
• NCI: Testicular Cancer Symptoms
• NCI SEER Stat Facts: Testicular Cancer

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

See an error, old source, or unclear wording? Tell us.